Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "2023"

1130 News Found

Aragen to operationalize Hyderabad formulation manufacturing facility by Jan 2023
News | October 21, 2022

Aragen to operationalize Hyderabad formulation manufacturing facility by Jan 2023

The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting


PGIMER Satellite Centre to be functional by Jan 2023: Dr. Mandaviya
Policy | August 22, 2022

PGIMER Satellite Centre to be functional by Jan 2023: Dr. Mandaviya

Phase 1 has already been executed with the construction of temporary OPD, guest house and boundary wall and Phase 2 of the execution is being fast tracked


Fortis Healthcare posts Q1 FY2023 consolidated PAT at Rs. 122.25 Cr
News | August 09, 2022

Fortis Healthcare posts Q1 FY2023 consolidated PAT at Rs. 122.25 Cr

The company has reported total income of Rs. 1508.55 crores during the period ended June 30, 2022.


Fortis Malar Hospitals posts Q1 FY2023 consolidated loss at Rs. 2.96 Cr
News | August 03, 2022

Fortis Malar Hospitals posts Q1 FY2023 consolidated loss at Rs. 2.96 Cr

The company has reported total income of Rs. 21.73 crores during the period ended June 30, 2022.


Astec LifeSciences Q1 FY2023 consolidated PAT drops to Rs. 11.39 Cr
News | July 26, 2022

Astec LifeSciences Q1 FY2023 consolidated PAT drops to Rs. 11.39 Cr

The company has reported total income of Rs. 186.97 crores during the period ended June 30, 2022.


Indian pharmaceutical companies to grow by 6-7% in FY2023: ICRA
News | July 16, 2022

Indian pharmaceutical companies to grow by 6-7% in FY2023: ICRA

ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.


Sanofi flu vaccines licensed and approved for 2022-2023 influenza season
Drug Approval | July 05, 2022

Sanofi flu vaccines licensed and approved for 2022-2023 influenza season

Sanofi will begin to ship their vaccines helping to ensure more people will be immunized


Dr. Reddy's Laboratories announces SBTi targets
Sustainability | December 12, 2025

Dr. Reddy's Laboratories announces SBTi targets

Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045


Granules’ packaging facility in US completes FDA inspection with zero observations
News | December 05, 2025

Granules’ packaging facility in US completes FDA inspection with zero observations

Granules Consumer Health serves as Granules’ front-end division for OTC products in the US